天麻素通过调控PI3K信号通路并降低活性氧水平减轻6-羟基多巴胺诱导的PC12细胞凋亡

张鑫宇 ,  温绍文 ,  赵斐 ,  吴丽丽 ,  张炅璐 ,  房泽海 ,  刘红杰

中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (9) : 1153 -1161.

PDF (7265KB)
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (9) : 1153 -1161. DOI: 10.12092/j.issn.1009-2501.2026.09.001
基础研究

天麻素通过调控PI3K信号通路并降低活性氧水平减轻6-羟基多巴胺诱导的PC12细胞凋亡

作者信息 +

Gastrodin attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by modulating the PI3K signaling pathway and reducing reactive oxygen species levels

Author information +
文章历史 +
PDF (7438K)

摘要

目的: 探讨天麻及其主要活性成分天麻素对帕金森病的潜在治疗机制,重点分析其在细胞凋亡、氧化应激及磷脂酰肌醇-3-激酶(PI3K)/RAC 丝氨酸/苏氨酸蛋白激酶(Akt)/丝氨酸/苏氨酸蛋白激酶 mTOR(mTOR)信号通路中的作用。方法: 采用 6-羟基多巴胺(6-OHDA)诱导的 PC12 细胞损伤模型,通过体外实验评估天麻素对细胞凋亡、细胞内活性氧水平及 PI3K/Akt/mTOR 信号通路相关蛋白表达的影响。结果: 实验结果表明,天麻素可显著改善 6-OHDA 诱导的 PC12 细胞凋亡,并对 PI3K 信号通路活性产生调控作用。此外,天麻素能够有效降低细胞内活性氧水平,该作用不依赖于 PI3K 信号通路的调控。结论: 天麻素可能通过降低细胞内活性氧水平并调控 PI3K/Akt/mTOR 信号通路的活性,协同发挥神经保护作用,从而减轻 6-OHDA 诱导的细胞凋亡,为其在帕金森病防治中的应用提供实验依据。

Abstract

AIM: To investigate the potential therapeutic mechanisms of Gastrodia elata and its main active component gastrodin (GSD) in Parkinson's disease (PD), focusing on apoptosis, oxidative stress, and the PI3K/Akt/mTOR signaling pathway. METHODS: A 6-hydroxydopamine (6-OHDA)-induced PC12 cell damage model was used to evaluate the effects of GSD on cell apoptosis, intracellular reactive oxygen species (ROS) levels, and the expression of PI3K/Akt/mTOR signaling pathway-related proteins in vitro. RESULTS: GSD significantly attenuated 6-OHDA-induced apoptosis in PC12 cells and modulated the activity of the PI3K signaling pathway. In addition, GSD effectively reduced intracellular ROS levels, and this effect was independent of PI3K pathway regulation. CONCLUSION: Gastrodin may exert neuroprotective effects by reducing intracellular ROS levels and modulating the PI3K/Akt/mTOR signaling pathway, thereby alleviating 6-OHDA-induced apoptosis in PC12 cells. These findings provide experimental evidence supporting the potential application of GSD in PD therapy.

关键词

天麻 / 天麻素 / PI3K/Akt/mTOR 信号通路 / 细胞凋亡

Key words

Gastrodia elata Blume / Gastrodin / PI3K/Akt/mTOR signaling pathway / cell apoptosis

引用本文

引用格式 ▾
张鑫宇,温绍文,赵斐,吴丽丽,张炅璐,房泽海,刘红杰. 天麻素通过调控PI3K信号通路并降低活性氧水平减轻6-羟基多巴胺诱导的PC12细胞凋亡[J]. 中国临床药理学与治疗学, 2026, 31(9): 1153-1161 DOI:10.12092/j.issn.1009-2501.2026.09.001

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Abbas MM, Xu Z, Tan LCS. Epidemiology of Parkinson's disease-east versus west[J].Mov Disord Clin Pract, 2018, 5(1): 14-28.

[2]

Collaborators GN. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet Neurol, 2019, 18(5): 459-480.

[3]

Narkiewicz J, Giachin G, Legname G. In vitro aggregation assays for the characterization of α-synuclein prion-like properties[J].Prion, 2014, 8(1): 19-32.

[4]

Winklhofer KF, Haass C.Mitochondrial dysfunction in Parkinson's disease[J].Biochim Biophys Acta, 2010, 1802(1): 29-44.

[5]

Wright R. Mitochondrial dysfunction and Parkinson's disease[J].Nat Neurosci, 2022, 25(1): 2.

[6]

刘娟, 李彦杰, 秦合伟, 等. 线粒体质量控制系统失调介导帕金森病的作用机制[J].实用医学杂志, 2024, 40(11): 1479-1482.

[7]

Meredith GE, Totterdell S, Potashkin JA, et al. Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol[J].Parkinsonism Relat Disord, 2008, 14 Suppl 2(Suppl 2): S112-S115.

[8]

Kalyanaraman B, Cheng G, Hardy M. Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: relevance to Parkinson's disease and therapeutic implications[J].Redox Biol, 2024, 71: 103092.

[9]

Schwienbacher C, Foco L, Picard A, et al. Plasma and white blood cells show different miRNA expression profiles in Parkinson's disease[J].J Mol Neurosci, 2017, 62(2): 244-254.

[10]

Poewe W, Seppi K, Tanner CM, et al. Parkinson disease[J].Nat Rev Dis Primers, 2017, 3: 17013.

[11]

Guo QQ, Wang SS, Jiang XY, et al. Mitochondrial ROS triggers mitophagy through activating the DNA damage response signaling pathway[J].Proc Natl Acad Sci U S A, 2025, 122(40): e2502841122.

[12]

Chou KL, Stacy M, Simuni T, et al. The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?[J].Parkinsonism Relat Disord, 2018, 51: 9-16.

[13]

Zhang G, Xiong N, Zhang Z, et al. Effectiveness of traditional Chinese medicine as an adjunct therapy for Parkinson's disease: a systematic review and meta-analysis[J].PLoS One, 2015, 10(3): e0118498.

[14]

韩欣园, 刘翼骁, 肖依彤, 等. 中药多糖治疗帕金森病的研究进展[J].中华神经医学杂志, 2025, 24(5): 524-531.

[15]

Leite Silva ABR, Gonçalves De Oliveira RW, Diógenes GP, et al. Premotor, nonmotor and motor symptoms of Parkinson's disease: a new clinical state of the art[J].Ageing Res Rev, 2023, 84: 101834.

[16]

姬之翼, 刘鸿高, 李杰庆, 等. 天麻化学成分、药理活性及质量标志物研究进展[J].特产研究, 2025: 1-12.

[17]

中华人民共和国药典 2020 版[M].北京: 中国医药科技出版社, 2020.

[18]

杨飞, 王信, 马传江, 等. 天麻加工炮制、成分分析与体内代谢研究进展[J].中国中药杂志, 2018, 43(11): 2207-2215.

[19]

Xia C, Zhou H, Xu X, et al. Identification and investigation of miRNAs from gastrodia elata blume and their potential function[J].Front Pharmacol, 2020, 11: 542405.

[20]

Dai Y, Ban W, Yang Z.Gastrodin, a promising natural small molecule for the treatment of central nervous system disorders, and its recent progress in synthesis, pharmacology and pharmacokinetics[J].Int J Mol Sci, 2024, 25(17): 9540.

[21]

He X, Chen X, Yang Y, et al. The role of gastrodin in the management of CNS-related diseases: underlying mechanisms to therapeutic perspectives[J].Phytother Res, 2024, 38(11): 5107-5133.

[22]

Luo S, Kang SS, Wang ZH, et al. Akt phosphorylates NQO1 and triggers its degradation, abolishing its antioxidative activities in Parkinson's disease[J].J Neurosci, 2019, 39(37): 7291-7305.

[23]

Payne JM, Haebich KM, Mitchell R, et al. Brain volumes in genetic syndromes associated with mTOR dysregulation: a systematic review and meta-analysis[J].Mol Psychiatry, 2025, 30(4): 1676-1688.

[24]

张炅璐. 天麻活性成分治疗帕金森病作用机制的网络药理学预测及实验研究[D].广州: 暨南大学, 2021.

[25]

Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030[J].Neurology, 2007, 68(5): 384-386.

[26]

Liu HJ, He TZ, Zhang JL, et al. [Systematic review and screening of basic Chinese herbs for traditional Chinese medicine compounds combined with levodopa medicine in treatment of Parkinson's disease][J].Zhongguo Zhong Yao Za Zhi, 2020, 45(24): 6043-6052.

[27]

Chun YS, Kim J, Chung S, et al. Protective roles of monsonia angustifolia and its active compounds in experimental models of Alzheimer's disease[J].J Agric Food Chem, 2017, 65(15): 3133-3140.

[28]

Ogut E, Armagan K, Gül Z.The role of syringic acid as a neuroprotective agent for neurodegenerative disorders and future expectations[J].Metab Brain Dis, 2022, 37(4): 859-880.

[29]

Kim IS, Choi DK, Jung HJ.Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells[J].Molecules, 2011, 16(7): 5349-5361.

[30]

Hu D, Qing G, Liu X, et al. A study and in vitro evaluation of the bioactive compounds of broad bean sprouts for the treatment of Parkinson's syndrome[J].Molecules, 2024, 29(21): 5107.

[31]

Xiao G, Tang R, Yang N, et al. Review on pharmacological effects of gastrodin[J].Arch Pharm Res, 2023, 46(9/10): 744-770.

[32]

Guo H, Li C, Zhao J, et al. Mechanism of gastrodin against neurotoxicity based on network pharmacology, molecular docking and experimental verification[J].Biomed Pharmacother, 2024, 180: 117611.

[33]

Zhan HD, Zhou HY, Sui YP, et al. The rhizome of Gastrodia elata Blume-An ethnopharmacological review[J].J Ethnopharmacol, 2016, 189: 361-385.

[34]

Liao W, Dong A, Hafeez F, et al. Celastrol protected the MPTP-injected mice Parkinson's disease model via redox regulation of CDC37[J].Phytomedicine, 2025, 145: 157067.

[35]

Yuan J, Ofengeim D.A guide to cell death pathways[J].Nat Rev Mol Cell Biol, 2024, 25(5): 379-395.

[36]

Czabotar PE, Garcia-saez AJ. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis[J].Nat Rev Mol Cell Biol, 2023, 24(10): 732-748.

[37]

Singh R, Letai A, Sarosiek K.Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins[J].Nat Rev Mol Cell Biol, 2019, 20(3): 175-193.

[38]

Kaur S, Sehrawat A, Mastana SS, et al. Targeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's disease[J].Life Sci, 2023, 330: 121995.

[39]

Nixon RA.Autophagy-lysosomal-associated neuronal death in neurodegenerative disease[J].Acta Neuropathol, 2024, 148(1): 42.

[40]

Yu L, Wei J, Liu P.Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J].Semin Cancer Biol, 2022, 85: 69-94.

[41]

Goyal A, Agrawal A, Verma A, et al. The PI3K-AKT pathway: a plausible therapeutic target in Parkinson's disease[J].Exp Mol Pathol, 2023, 129: 104846.

[42]

Yang S, Lian G.ROS and diseases: role in metabolism and energy supply[J].Mol Cell Biochem, 2020, 467(1/2): 1-12.

[43]

Song J, Wang Y, Yuan X, et al. Stretching magnitude-dependent inactivation of AKT by ROS led to enhanced p53 mitochondrial translocation and myoblast apoptosis[J].Mol Biol Cell, 2019, 30(10): 1182-1197.

基金资助

国家自然科学基金面上项目(82074306)

第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]239 号)

AI Summary AI Mindmap
PDF (7265KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉